(AOF) – Carmat has reached an agreement with all of its financial creditors on new terms for repaying its bank loans. This agreement follows the conditional agreements in principle announced on January 12 and February 22. It covers all of the company’s bank loans, including the loan for a principal amount of 30 million euros contracted with the European Investment Bank and the two loans guaranteed by the State of principal amount of 5 million euros each, contracted with Bnp Paribas and Bpifrance.
“Its implementation allows us to extend the maturity of all our financial debts by at least two years, and thus reduce our loan repayments by more than 30 million euros over the period 2024-2025. We will be able to therefore, during this period, allocate our financial resources primarily to the service of our growth, but also significantly reduce the company’s financing needs”, explained the general director, Stéphane Piat.
Taking into account this agreement and its cash flow situation, the medtech can finance its activities, according to its current business plan, until mid-May 2024, and estimates its financing need over the next 12 months at around €35 million. euros.
Carmat continues to work very actively on other initiatives to strengthen its equity in the short term and alleviate its cash flow constraints, and thus be able to continue its activities beyond mid-May 2024.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
